Abstract submission period

Oral presentations: March 28 to May 9, 2023 at noon.（Japan Standard Time）
Designated presentations: Nominated speakers will be contacted individually.

Submission of abstracts

• Abstracts must be submitted online via the UMIN system.
• The text of the abstract can be prepared in Japanese or English
• Speakers at sessions with other speakers from overseas are requested to submit their abstracts in English.
• The presenter is the first author of an oral presentation.
• Foreign national presenters (of oral presentations) who are currently studying in Japan are exempt from registration fees.

Presentation style

Oral presentations

1. Oral Japanese presentation.
2. Oral English presentation.
3. Poster presentation.

Please select 1,2, or 3. However, we may not be able to meet your request.　After peer review by the program committee, we will let you know acceptance or rejection of abstracts, the style of presentation, presentation number, and other details by E-mail by the end of July.

Designated resentations

Oral presentation only

* If you require any special considerations on the day of the presentation, please provide details by checking the relevant box when submitting your abstract (i.e., use of a wheelchair, etc.)

Awards

1. Excellent Poster Award

Awards will be presented to the best poster presentations.
Requirements: First author must be under 40 years of age (as of April 1, 2023). If you wish to apply for the Award, please indicate it at the time of your abstract submission.

2. English Presentation Award

Awards will be presented for the best oral presentations in English.
Requirements: No age restriction. No need to apply for it.

3.Yes-Japan Award

Awards will be presented to the best poster presentations.
Requirements: First author must be under 40 years of age and a medical student, young physician’s early career, or a medical staff.

4. Award

The awarding ceremony will be held on the last day of the exhibition.

Eligibility and conditions

Ethical considerations

Abstracts will be accepted for peer review following confirmation that there are no ethical issues related to the study. Presenters must adhere to the “Declaration of Helsinki” and must bear ethical responsibility for their presentations. Please answer the questions concerning ethical issues at the time of abstract submission. If there are no ethical issue with the contents of your presentation, you do not have to state that in the abstract. Please make certain that you do not disclose private information regarding patients involved in the study.

Abstract overlap

All abstracts must be original and previously unpublished. If your abstract for this congress overlaps with one for another presentation, please send a copy of the other abstract to the Secretariat of the 56th Annual Congress of the Japan Epilepsy Society.

35th International Epilepsy Congress and 56th JES do not compete with each other, and international and domestic abstracts are considered as separate.

JES membership status of first author

The first author must be a regular member or temporary member of the Japan Epilepsy Society. If you are not a member, please apply for membership at the time of abstract submission. More than one regular member must be included as a co-author when a presentation is given by a temporary member.

To apply for membership, please contact the Secretariat of the Japan Epilepsy Society:

Points to note when submitting an abstract

Number of words

Oral Presentation (Japanese, English) and Poster Presentation

Designated Presentation

* Please structure the abstract using the following headings: Objectives, Subjects and Methods, Results, Conclusion.

Presentation format or session title for designated presentation

* Please select one of the following.

Oral Presentation

Designated Presentation

Category

If you have selected Oral Presentation as your presentation format, please select your first and second choice categories from the list below.

Disclosure of Conflicts of Interest (COI)

• The method of reporting COI has been changed.
  Please answer the "Conflict of Interest (COI)" questions in the system at the time of abstract submission.
• For the detailed information on the Policy on Conflicts of Interest (COI) in Clinical Research, click here.
• Please contact the Secretariat of the Japan Epilepsy Society (see below) for any technical questions on COI.

COI Disclosure Form (Template) for Oral and Poster Presentations

Form 2: Disclosure of COI

Abstract submission

Create a new abstract

• Encrypted file
• Plain text

Login to Confirm, Modify, or Delete an existing abstract

• Encrypted file
• Plain text